Insider Selling: Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK) Director Sells 8,000 Shares

Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRKGet Free Report) Director Charles Mueller, Jr. sold 8,000 shares of the stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $63.90, for a total value of $511,200.00. Following the completion of the sale, the director owned 16,084 shares of the company’s stock, valued at $1,027,767.60. The trade was a 33.22% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Vivmark Residential Common Shares of Beneficial Interest Price Performance

NYSE:VMRK traded up $0.38 on Wednesday, reaching $64.41. 6,131,899 shares of the company’s stock traded hands, compared to its average volume of 4,406,111. Vivmark Residential Common Shares of Beneficial Interest has a 12 month low of $57.57 and a 12 month high of $71.50. The stock has a market cap of $24.15 billion, a PE ratio of 15.77, a P/E/G ratio of 5.37 and a beta of 0.73. The company has a quick ratio of 0.19, a current ratio of 0.19 and a debt-to-equity ratio of 0.77.

Vivmark Residential Common Shares of Beneficial Interest News Summary

Here are the key news stories impacting Vivmark Residential Common Shares of Beneficial Interest this week:

  • Positive Sentiment: Stifel Nicolaus maintained a “buy” rating and trimmed its price target only slightly, from $79.00 to $78.50. The target remains well above the recent trading level, signaling continued confidence in Vivmark’s potential. Benzinga article
  • Positive Sentiment: Evercore initiated coverage with an “in-line” rating and a $72.00 price target. Although not an outright bullish rating, the target indicates potential appreciation and adds institutional research coverage. Tickerreport article
  • Positive Sentiment: Zacks Research raised its FY2026 EPS forecast from $4.06 to $4.07, FY2027 EPS from $4.20 to $4.21, and Q1 2027 EPS from $1.00 to $1.02. These increases suggest slightly improved expectations for near- and medium-term profitability.
  • Neutral Sentiment: The analyst consensus still projects steady earnings progression, including approximately $4.40 in FY2028 EPS, but the revisions are small and do not represent a major change to Vivmark’s outlook.
  • Negative Sentiment: Zacks lowered estimates for Q3 2026, Q2 2027, Q3 2027, Q1 2028, and FY2028. The FY2028 forecast declined from $4.43 to $4.40, indicating modest pressure on longer-term earnings expectations.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the company. Evercore initiated coverage on Vivmark Residential Common Shares of Beneficial Interest in a research note on Tuesday. They set an “in-line” rating and a $72.00 target price on the stock. Stifel Nicolaus cut their price objective on shares of Vivmark Residential Common Shares of Beneficial Interest from $79.00 to $78.50 and set a “buy” rating for the company in a report on Wednesday. One research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $75.25.

Get Our Latest Stock Analysis on Vivmark Residential Common Shares of Beneficial Interest

About Vivmark Residential Common Shares of Beneficial Interest

(Get Free Report)

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, DC, Seattle, San Francisco, Southern California and Denver.

See Also

Receive News & Ratings for Vivmark Residential Common Shares of Beneficial Interest Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivmark Residential Common Shares of Beneficial Interest and related companies with MarketBeat.com's FREE daily email newsletter.